EUVIMEDEUVIMED entdecken
Crossref

Synergizing autophagic cell death and oxaliplatin-induced immunogenic death by a self-delivery micelle for enhanced tumor immunotherapy

Tao Deng, Dong Chen, Fang Chen, Chaoqun Xu, Qiang Zhang, Min Li, Yashi Wang, Zhidi He, Man Li, Qin He

Acta Biomaterialia · 2024

DOI: 10.1016/j.actbio.2024.10.025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2024. Verfasst von Tao Deng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-So…. Hauptthemen laut MEDLINE: Micelles, Oxaliplatin, Autophagy, Immunotherapy. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sichuan Province Science and Technology Support Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapy has become an emerging strategy to activate cytotoxic T cell responses by inducing immunogenic cell death (ICD), but the level of antitumor immunity induced by chemotherapeutic agents, such as oxaliplatin (OXA), is limited due to inadequate tumor antigen presentation and T cell activation. Inducing autophagic cell death (ACD) promotes the release of tumor antigen and the recruitment of dendritic cells, therefore strengthening antitumor immune responses. Here we simultaneously activate ICD and ACD with tumor targeting micelle to achieve enhanced antitumor chemo-immunotherapy. A self-delivery micelle is formulated by conjugating OXA prodrug with tocopherol succinate (TOS) as a hydrophobic segment and further encapsulates autophagy activator SMER28 to afford TOPR/SMER28, which specifically targets αvβ3 on tumor cells with c(RGDfK). Upon cellular internalization, OXA is released from the prodrug in response to the high concentration of reduced glutathione (GSH) in tumor cells, triggering ICD and releasing associated molecular patterns (DAMPs) signaling molecules to stimulate immunity. Meanwhile, SMER28 over-activates autophagy to induce autophagic cell death, which further leads to the maturation of dendritic cells and ultimately activates anti-tumor immune response. In the 4T1 tumor-bearing mice, the combination of OXA and SMER28 effectively inhibits tumor growth and activates antitumor immune responses. The tumor targeted micelle releases OXA and SMER28 in an on-demand profile and strengthens tumor chemo-immunotherapy by synergizing ICD and ACD, providing an alternative for antitumor immunotherapy. STATEMENT OF SIGNIFICANCE: Chemotherapy induces immunogenic cell death (ICD) to activate anti-tumor immunity. However, the efficacy is limited by low levels of antigen presentation and T cell activation. To strengthen the antitumor immune responses induced by ICD, we first combine autophagic cell death (ACD) with ICD by formulating a glutathione-responsive oxaliplatin prodrug micelle co-encapsulating the autophagy activator SMER28. The activated autophagic level by SMER28 enhances the release of antigen and the recruitment of APCs, and ultimately bolsters T cell-mediated antitumor immune responses. We provide a potential strategy to amplify antitumor immune effects by combining autophagy activation with chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicellesOxaliplatinAutophagyImmunotherapyImmunogenic Cell DeathAnimalsCell Line, TumorMiceMice, Inbred BALB CFemaleAntineoplastic AgentsHumansDendritic CellsNeoplasmsProdrugs

Stichwörter der Autor:innen

Autophagic cell deathImmunogenic cell deathOxaliplatinPolymeric micelleTumor immunotherapy

Substanzen

MicellesOxaliplatinAntineoplastic AgentsProdrugs

Autor:innen und Institutionen

  • Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Centre for Drug Precision Industrial T…
  • Sichuan Academy of Chinese Medicine Science, Chengdu, 610041, PR China.

Förderung

  • National Natural Science Foundation of China
  • Sichuan Province Science and Technology Support Program

Zitieren

APA

Deng, T., Chen, D., Chen, F., Xu, C., Zhang, Q., Li, M., Wang, Y., He, Z., Li, M., & He, Q. (2024). Synergizing autophagic cell death and oxaliplatin-induced immunogenic death by a self-delivery micelle for enhanced tumor immunotherapy. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2024.10.025

Vancouver

Deng T, Chen D, Chen F, Xu C, Zhang Q, Li M, et al. Synergizing autophagic cell death and oxaliplatin-induced immunogenic death by a self-delivery micelle for enhanced tumor immunotherapy. Acta Biomaterialia. 2024. doi:10.1016/j.actbio.2024.10.025

BibTeX
@article{Deng2024,
  author = {Deng, Tao and Chen, Dong and Chen, Fang and Xu, Chaoqun and Zhang, Qiang and Li, Min and Wang, Yashi and He, Zhidi and Li, Man and He, Qin},
  title = {Synergizing autophagic cell death and oxaliplatin-induced immunogenic death by a self-delivery micelle for enhanced tumor immunotherapy},
  journal = {Acta Biomaterialia},
  year = {2024},
  doi = {10.1016/j.actbio.2024.10.025}
}
Kostenlos starten →